Victrex plc (LON:VCT) Stock Has Consensus Target Price of GBX 807.86

Victrex plc (LON:VCT) has earned an average recommendation of “Hold” from the seven brokerages that are currently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and one has given a buy recommendation to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is GBX 807.86.

Several equities analysts have recently commented on VCT shares. Canaccord Genuity Group upped their price objective on shares of Victrex from GBX 725 to GBX 1,050 and gave the stock a “buy” rating in a report on Tuesday, September 29th. Citigroup increased their price objective on shares of Victrex from GBX 700 to GBX 1,000 and gave the stock a “neutral” rating in a research report on Friday, September 11th. Berenberg Bank lifted their target price on shares of Victrex from GBX 680 to GBX 870 and gave the company a “hold” rating in a report on Friday, September 11th. JPMorgan Chase & Co. boosted their target price on Victrex from GBX 625 to GBX 785 and gave the company a “neutral” rating in a research report on Thursday, September 10th. Finally, Jefferies Financial Group reissued a “hold” rating and issued a GBX 595 target price on shares of Victrex in a research report on Friday, September 25th.

Victrex Trading Down 0.6%

Shares of VCT stock opened at GBX 926.26 on Thursday. The company has a debt-to-equity ratio of 21.30, a current ratio of 2.35 and a quick ratio of 1.99. The firm has a market cap of £807.29 million, a PE ratio of -41.35, a price-to-earnings-growth ratio of 1.92 and a beta of 0.76. The company has a 50-day moving average of GBX 888.55 and a two-hundred day moving average of GBX 727.06. Victrex has a 1-year low of GBX 515 and a 1-year high of GBX 1,024.

Victrex Company Profile

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.